Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berger

Showing results (1111-1120 of 1,161) with videos related to

Pageof 117
Sort By:
Nature Genetics|November 6, 2021
The context-specific role of germline pathogenicity in tumorigenesisPreethi Srinivasan, Chaitanya Bandlamudi, Philip Jonsson, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancerAnton Safonov, Antonio Marra, Chaitanya Bandlamudi, et al.
Nature Medicine|October 16, 2023
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockadeEmily C Harrold, Michael B Foote, Benoit Rousseau, et al.
Cancer Discovery|November 23, 2018
<i>EGFR</i> and <i>MET</i> Amplifications Determine Response to HER2 Inhibition in <i>ERBB2</i>-Amplified Esophagogastric CancerFrancisco Sanchez-Vega, Jaclyn F Hechtman, Pau Castel, et al.
Nature|February 11, 2011
The genomic complexity of primary human prostate cancerMichael F Berger, Michael S Lawrence, Francesca Demichelis, et al.
JCO Precision Oncology|September 22, 2023
Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian CancerTiffany Y Sia, Anna Maio, Yelena M Kemel, et al.
The New England Journal of Medicine|September 10, 2015
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaEnrico Tiacci, Jae H Park, Luca De Carolis, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Science (New York, N.Y.)|July 30, 2011
The mutational landscape of head and neck squamous cell carcinomaNicolas Stransky, Ann Marie Egloff, Aaron D Tward, et al.
JCO Precision Oncology|August 22, 2017
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision MakingWassim Abida, Joshua Armenia, Anuradha Gopalan, et al.
Pageof 117

Showing results (1111-1120 of 1,161) with videos related to

Sort By:
Pageof 117
Nature Genetics|November 6, 2021
The context-specific role of germline pathogenicity in tumorigenesisPreethi Srinivasan, Chaitanya Bandlamudi, Philip Jonsson, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancerAnton Safonov, Antonio Marra, Chaitanya Bandlamudi, et al.
Nature Medicine|October 16, 2023
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockadeEmily C Harrold, Michael B Foote, Benoit Rousseau, et al.
Cancer Discovery|November 23, 2018
<i>EGFR</i> and <i>MET</i> Amplifications Determine Response to HER2 Inhibition in <i>ERBB2</i>-Amplified Esophagogastric CancerFrancisco Sanchez-Vega, Jaclyn F Hechtman, Pau Castel, et al.
Nature|February 11, 2011
The genomic complexity of primary human prostate cancerMichael F Berger, Michael S Lawrence, Francesca Demichelis, et al.
JCO Precision Oncology|September 22, 2023
Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian CancerTiffany Y Sia, Anna Maio, Yelena M Kemel, et al.
The New England Journal of Medicine|September 10, 2015
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaEnrico Tiacci, Jae H Park, Luca De Carolis, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Science (New York, N.Y.)|July 30, 2011
The mutational landscape of head and neck squamous cell carcinomaNicolas Stransky, Ann Marie Egloff, Aaron D Tward, et al.
JCO Precision Oncology|August 22, 2017
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision MakingWassim Abida, Joshua Armenia, Anuradha Gopalan, et al.
Pageof 117